Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
复制标题
DOI：
10.1016/j.cllc.2016.06.007
复制
发表时间：
2017-01
影响因子：
3.6
通讯作者：
Wakelee HA
中科院分区：
文献类型：
--
作者：
Salahudeen AA;Patel MI;Baas P;Curran WJ;Bradley JD;Gandara DR;Goss GD;Mok TS;Ramalingam SS;Vokes EE;Malik SM;Wakelee HA
早期和晚期非小细胞肺癌（NSCLC）患者的生存率随着新的全身治疗和放射技术（包括联合治疗方案、靶向治疗和免疫治疗）而提高。癌症合作小组历来在非小细胞肺癌治疗的发展中发挥着关键作用。每年，来自世界各地的合作团体的代表聚集在国际肺癌大会（ILCC）。2015年夏天，ILCC迎来了成立16周年。本文重点介绍了2015年参与研究组提交的NSCLC研究。
Survival rates of patients with either early and advanced stage non–small-cell lung cancer (NSCLC) have improved with newer systemic therapy and radiation techniques, including combination regimens, targeted therapies, and immunotherapies. The cancer cooperative groups have historically played a critical role in the advancement of NSCLC therapy. Annually, representatives from cooperative groups worldwide convene at the International Lung Cancer Congress (ILCC). In summer 2015, the ILCC reached its 16th anniversary. This article highlights the NSCLC studies presented by participating groups in 2015.